For research use only. Not for therapeutic Use.
RET V804M-IN-1(Cat No.:I015177)is a small-molecule inhibitor specifically designed to target the RET receptor tyrosine kinase carrying the gatekeeper mutation V804M. This mutation is clinically significant as it often confers resistance to several first-generation RET inhibitors in medullary thyroid carcinoma and non-small cell lung cancer. RET V804M-IN-1 suppresses oncogenic RET signaling by blocking phosphorylation and downstream pathways such as MAPK/ERK. It serves as a valuable tool for studying RET-driven tumor biology, drug resistance mechanisms, and the development of next-generation targeted cancer therapeutics.
CAS Number | 2414909-94-5 |
Synonyms | 4-[5-(pyridin-3-ylmethylamino)pyrazolo[1,5-a]pyrimidin-3-yl]benzamide |
Molecular Formula | C19H16N6O |
Purity | ≥95% |
IUPAC Name | 4-[5-(pyridin-3-ylmethylamino)pyrazolo[1,5-a]pyrimidin-3-yl]benzamide |
InChI | InChI=1S/C19H16N6O/c20-18(26)15-5-3-14(4-6-15)16-12-23-25-9-7-17(24-19(16)25)22-11-13-2-1-8-21-10-13/h1-10,12H,11H2,(H2,20,26)(H,22,24) |
InChIKey | LMGXQBQAUALFTB-UHFFFAOYSA-N |
SMILES | C1=CC(=CN=C1)CNC2=NC3=C(C=NN3C=C2)C4=CC=C(C=C4)C(=O)N |
Chemistry Calculators | Dilution Calculator In vivo Formulation Calculator Molarity Calculator Molecular Weight Calculator Reconstitution Calculator |